JW Choongwae Pharmaceutical proves lipid-improving effect as a result of Phase 3 clinical trial of RivaroJet’NDA application’
JW Choongwae Pharmaceutical proves the effect of improving lipids in phase 3 clinical trials of ribarojet
Chong Kun Dang, “Challenge for official approval as a phase 3 clinical trial for Napabeltan corona treatment”
Ministry of Food and Drug Safety “Chong Kun Dang Corona 19 Treatment Needs Additional Clinical Trials”
Chong Kun Dang corona treatment drug that could not penetrate the 1st gateway… Engineers rehabilitated to phase 3 clinical trials?